Category: HCP Engagement

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

Off Label Spending – Using Transparency Data to Sniff Out Clues

Since 2013, Federal regulators have stepped up scrutiny of the relationships between pharmaceutical manufacturers and healthcare providers. Considering the potential fines that are in place, this isn’t a time when companies can sit back complacently. Instead, they must dedicate this time to verifying the accuracy of their data and reporting systems so they can identify […]

Next Generation Compliance: Using Analytics to Reduce Compliance Risks

Government agencies are increasingly using publicly available data sets in support of their allegations against pharmaceutical and device manufacturing companies. A recent example is the government’s allegation of kickbacks against Insys Therapeutics, Inc. and their use of both Open payments and Medicare Part D data. Managing the Risk of Open Payments Data CMS published the […]

Importance and Responsibilities of Ethics and Compliance Officers for Pharma Manufacturers

Pharma manufacturers, for the very first time, are revealing how much they have spent on HCOs and HCPs . By 30th June 2016, all pharma manufacturers will be required to publish payments made to healthcare professionals. Pharma manufacturers have made mistakes in the past, but these are evolving rapidly. Non-duplication of data is one major […]